Hemanext Funding: $130M Raised, Series B (2024)

Hemanext funding overview

Hemanext is based in Lexington, Massachusetts. Hemanext has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2024. The round record for Hemanext runs through 2024; nothing later has been disclosed. Investors on record include Omega Family Office, Antaeus Enterprises, Inc., The Testa Family Office, Grabe Family Office, The Eduardo Avayu Family Office, Stephen Eckert and 1 others. 7 distinct backers are named across the disclosed rounds.

Hemanext at a glance

Total raised: $130M
Latest round: Series B
Latest round date: October 2024
Headquarters: Lexington, Massachusetts
Notable investors: Omega Family Office, Antaeus Enterprises, Inc., The Testa Family Office, Grabe Family Office, The Eduardo Avayu Family Office, Stephen Eckert, Dr. Ismail Kola

Frequently asked about Hemanext funding

How much has Hemanext raised?: Hemanext has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Hemanext?: Omega Family Office, Antaeus Enterprises, Inc., The Testa Family Office, Grabe Family Office, The Eduardo Avayu Family Office, Stephen Eckert are named among the investors backing Hemanext.
What was the latest Hemanext funding round?: The most recent disclosed round is a Series B, announced in October 2024.
Where is Hemanext based?: Hemanext is based in Lexington, Massachusetts.
When did Hemanext last raise?: The last disclosed Hemanext round closed in October 2024 at Series B.

Round data for Hemanext is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Lexington and backer lists below.

Hemanext Funding: $130M Raised, Series B (2024)

Hemanext funding overview

Hemanext at a glance

Frequently asked about Hemanext funding

Companies related to Hemanext (12)

Browse related funding lists (3)